HC Wainwright & Co. Reiterates Rewalk Robotics (RWLK) Buy Recommendation
NASDAQ · 05/12 14:11
HC Wainwright & Co. Reiterates Buy on ReWalk Robotics, Maintains $3 Price Target
Benzinga · 05/12 10:55
ReWalk Q1: 40% Revenue Growth, Expanding Margins, Europe Snag & More
Benzinga · 05/11 15:26
ReWalk Robotics (RWLK) Reports Q1 Loss, Misses Revenue Estimates
NASDAQ · 05/11 13:15
BRIEF-ReWalk Robotics Ltd Reports Quarterly Loss Per Share Of $0.07
Reuters · 05/11 13:04
Recap: ReWalk Robotics Q1 Earnings
Benzinga · 05/11 12:09
ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates
NASDAQ · 05/10 21:35
Notable earnings before Thursday's open
Seeking Alpha · 05/10 15:12
Artivion (AORT) Q1 Earnings and Revenues Beat Estimates
NASDAQ · 05/04 22:25
ReWalk Robotics To Provide First U.S. Demonstrations Of Groundbreaking Stairs-Enabled Exoskeleton Technology
Benzinga · 05/04 12:37
BRIEF-Rewalk Robotics Received Notification On Additional Period To Regain Compliance With Nasdaq
Reuters · 04/14 13:55
On April 11, Rewalk Robotics Received Notification Letter From Nasdaq Providing Co Additional Period Until Oct 9, To Regain Compliance With Nasdaq
Benzinga · 04/14 12:11
Allbirds And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
Benzinga · 03/17 11:13
Lind Global Fund II Now Owns 16.10% of Rewalk Robotics (RWLK)
NASDAQ · 03/09 22:36
Over $395M Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Benzinga · 03/09 11:47
Rewalk Robotics (RWLK) Gets a Buy from H.C. Wainwright
TipRanks · 03/08 13:45
BRIEF-Advancement In Rewalk Technology Achieves FDA Clearance As Only Personal Exoskeleton To Enable Use On Stairs And Curbs
Reuters · 03/07 13:22
ReWalk Robotics Receives FDA Approval for Personal Exoskeleton Technology
ReWalk Robotics Receives FDA Approval for Personal Exoskeleton Technology
MT Newswires · 03/07 11:46
On March 6, 2023, ReWalk Robotics Announced That Its ReWalk Personal Exoskeleton Technology Received Clearance From The U.S. Food And Drug Administration For Use On Stairs And Curbs In The United States; Shares Spike Higher
Benzinga · 03/06 17:29
ReWalk Robotics Gets FDA 510(k) Approval For ReWalk P6.0 Exoskeleton
Benzinga · 03/06 14:50
Webull provides a variety of real-time RWLK stock news. You can receive the latest news about Rewalk Robotics through multiple platforms. This information may help you make smarter investment decisions.
About RWLK
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.